Resumo

AGUILAR-URBINA, Edi William et al. Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report. Rev. Cuerpo Med. HNAAA [online]. 2021, vol.14, n.3, pp.394-397.  Epub 26-Nov-2021. ISSN 2225-5109.  http://dx.doi.org/10.35434/rcmhnaaa.2021.143.1280.

Background: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presented with a diagnosis of bullous fixed pigmented erythema secondary to the ingestion of ivermectin. It is necessary for the physician to recognize the adverse effects of self-medication with ivermectin against SARS CoV-2, to make an early diagnosis and initiate timely treatment.

Palavras-chave : Bullous pigmented fixed erythema; toxicoderma; drug erythema pigmentation.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )